On the surface, the formula for weight loss seems simple: eat less and move more. But giving that advice to someone with ...

IT’S become one of the most popular ways in the showbiz world to stay slim. But Katherine Ryan has hit back at claims she’s ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

There are currently three medications (GLP-1s) on the market that the FDA has specifically approved to treat obesity — Wegovy, Zepbound, or Saxenda. Other common weight-loss medications like ...